Hypertrophic cardiomyopathy in childhood.

Steven D Colan

Journal: Heart failure clinics 2011;6(4):433-44, vii-iii

PMID: 20869644

Free Full Text on PubMed Central View on PubMed

Abstract

Hypertrophic cardiomyopathy has important differences in children compared with adults, particularly with regard to the range of causes and the outcomes in infants. Survival is highly dependent on etiology, particularly in the youngest patients, and pursuit of the specific cause is therefore necessary. The clinical utility of defining the genotype in children with familial hypertrophic cardiomyopathy exceeds that at other ages and has a highly favorable cost/benefit ratio. Although most of the available information concerning treatment and prevention of sudden death is derived in adults, management of children requires consideration of the differences in age-specific risk/benefit ratios.

Address: Department of Cardiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. [email protected]

DOI: 10.1016/j.hfc.2010.05.004

Link outs

Free resources

Full Text Sources:

Subscription / membership required

Full Text Sources:

MeSH Terms: Ablation Techniques, Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Arrhythmias, Cardiac, Calcium Channel Blockers, Cardiomyopathy, Hypertrophic, Child, Death, Sudden, Defibrillators, Implantable, Ethanol, Exercise, Genetic Predisposition to Disease, Heart Septum, Humans, Magnetic Resonance Imaging, Myocardial Bridging, Myocardium, Pacemaker, Artificial, Severity of Illness Index, Syncope, Ventricular Outflow Obstruction